Illness tracking in SARS-CoV-2 tested persons using a smartphone app: a non-interventional, prospective, cohort study.
Ageusia
COVID-19
SARS-CoV-2 infection
agnosia
app
illness
omicron
remote monitoring
symptoms
tiredness
Journal
New microbes and new infections
ISSN: 2052-2975
Titre abrégé: New Microbes New Infect
Pays: England
ID NLM: 101624750
Informations de publication
Date de publication:
Mar 2022
Mar 2022
Historique:
received:
04
01
2022
revised:
17
02
2022
accepted:
01
03
2022
pubmed:
16
3
2022
medline:
16
3
2022
entrez:
15
3
2022
Statut:
ppublish
Résumé
There are few data on the range and severity of symptoms of SARS-CoV-2 infection or the impact on life quality in infected, previously healthy, young adults such as Swiss Armed Forces personnel. It is also unclear if an app can be used to remotely monitor symptoms in persons who test positive. Using a smartphone app called ITITP (Illness Tracking in Tested Persons) and weekly pop-up questionnaires, we aimed to evaluate the spectrum, duration, and impact of symptoms reported after a positive SARS-CoV-2 test according to sex, age, location, and comorbidities, and to compare these to responses from persons who tested negative. We followed up 502 participants (57% active participation), including 68 (13.5%) positive tested persons. Hospitalisation was reported by 6% of the positive tested participants. We found that positives reported significantly more symptoms that are typical of COVID-19 compared to negatives. These symptoms with odds ratio (OR > 1) were
Identifiants
pubmed: 35287272
doi: 10.1016/j.nmni.2022.100967
pii: S2052-2975(22)00019-1
pmc: PMC8908571
doi:
Types de publication
Journal Article
Langues
eng
Pagination
100967Informations de copyright
© 2022 The Author(s).
Déclaration de conflit d'intérêts
None declared.
Références
Lancet Digit Health. 2021 Sep;3(9):e587-e598
pubmed: 34334333
Internet Interv. 2021 Dec;26:100464
pubmed: 34631433
Lancet. 2020 Mar 28;395(10229):1054-1062
pubmed: 32171076
Travel Med Infect Dis. 2021 Mar-Apr;40:101995
pubmed: 33631340
Nat Rev Genet. 2021 Dec;22(12):757-773
pubmed: 34535792
PLoS One. 2020 Jun 23;15(6):e0234765
pubmed: 32574165
MMWR Morb Mortal Wkly Rep. 2021 Jan 22;70(3):88-94
pubmed: 33476314
Nat Med. 2020 Jul;26(7):1037-1040
pubmed: 32393804
MMWR Morb Mortal Wkly Rep. 2020 Jul 31;69(30):993-998
pubmed: 32730238
Sci Rep. 2021 Nov 23;11(1):22777
pubmed: 34815503
Clin Infect Dis. 2021 Feb 16;72(4):598-603
pubmed: 32594121
Lancet Infect Dis. 2022 Mar;22(3):299-301
pubmed: 34843663
Eur J Clin Invest. 2021 Apr;51(4):e13520
pubmed: 33583018
BMJ. 2020 Mar 17;368:m1066
pubmed: 32184233
Proc Natl Acad Sci U S A. 2021 Jan 26;118(4):
pubmed: 33431650